NexGel (NXGL) Competitors $2.36 -0.02 (-0.84%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$2.37 +0.01 (+0.42%) As of 07/25/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. SRTS, ZYXI, CTSO, RBOT, MDAI, SURG, ICCM, SPAI, EDAP, and QTIShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Sensus Healthcare (SRTS), Zynex (ZYXI), Cytosorbents (CTSO), Vicarious Surgical (RBOT), Spectral AI (MDAI), SurgePays (SURG), IceCure Medical (ICCM), Safe Pro Group (SPAI), Edap Tms (EDAP), and QT Imaging (QTI). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Sensus Healthcare Zynex Cytosorbents Vicarious Surgical Spectral AI SurgePays IceCure Medical Safe Pro Group Edap Tms QT Imaging Sensus Healthcare (NASDAQ:SRTS) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership. Is SRTS or NXGL more profitable? Sensus Healthcare has a net margin of 4.56% compared to NexGel's net margin of -30.80%. Sensus Healthcare's return on equity of 3.34% beat NexGel's return on equity.Company Net Margins Return on Equity Return on Assets Sensus Healthcare4.56% 3.34% 3.00% NexGel -30.80%-54.95%-27.84% Do institutionals & insiders have more ownership in SRTS or NXGL? 25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 8.9% of Sensus Healthcare shares are held by insiders. Comparatively, 20.6% of NexGel shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk & volatility, SRTS or NXGL? Sensus Healthcare has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, NexGel has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Do analysts rate SRTS or NXGL? Sensus Healthcare presently has a consensus price target of $11.67, suggesting a potential upside of 111.74%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Sensus Healthcare is more favorable than NexGel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger valuation and earnings, SRTS or NXGL? Sensus Healthcare has higher revenue and earnings than NexGel. NexGel is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensus Healthcare$41.81M2.17$6.65M$0.1055.10NexGel$8.69M2.08-$3.28M-$0.45-5.24 Does the media refer more to SRTS or NXGL? In the previous week, Sensus Healthcare had 2 more articles in the media than NexGel. MarketBeat recorded 3 mentions for Sensus Healthcare and 1 mentions for NexGel. NexGel's average media sentiment score of 1.89 beat Sensus Healthcare's score of 0.47 indicating that NexGel is being referred to more favorably in the news media. Company Overall Sentiment Sensus Healthcare Neutral NexGel Very Positive SummarySensus Healthcare beats NexGel on 14 of the 16 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.19M$6.85B$5.70B$9.50BDividend YieldN/A1.27%4.60%4.01%P/E Ratio-5.2425.4528.1020.06Price / Sales2.0864.10429.3889.33Price / CashN/A20.5536.2258.56Price / Book2.624.758.665.87Net Income-$3.28M$176.14M$3.25B$258.55M7 Day Performance-2.48%2.92%4.22%3.73%1 Month Performance-1.67%3.23%10.51%11.75%1 Year Performance-24.84%7.28%34.40%18.02% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel0.8562 of 5 stars$2.36-0.8%N/A-11.4%$18.19M$8.69M-5.2410Positive NewsSRTSSensus Healthcare1.1298 of 5 stars$4.52-1.7%$11.67+158.1%-13.1%$74.66M$39.49M45.4040News CoverageZYXIZynex2.143 of 5 stars$2.44+4.3%$5.50+125.4%-74.7%$73.82M$192.35M-10.17770CTSOCytosorbents1.6634 of 5 stars$1.06+1.9%$5.50+418.9%-8.4%$66.37M$35.60M-3.79220Gap UpRBOTVicarious Surgical0.3741 of 5 stars$10.62+3.3%$8.50-19.9%+46.6%$62.95MN/A-1.02210Gap DownMDAISpectral AI3.5169 of 5 stars$2.44-0.2%$4.75+95.1%+46.9%$61.65M$29.96M-4.5183SURGSurgePays3.2901 of 5 stars$2.98+0.7%$9.00+202.0%-2.0%$60.82M$60.88M-1.0740ICCMIceCure Medical2.3314 of 5 stars$0.99-2.5%$2.50+152.5%+33.8%$57.82M$3.29M-3.5260News CoverageGap UpSPAISafe Pro Group0.7136 of 5 stars$3.80+1.6%$8.00+110.5%N/A$57.65M$2.17M-4.6911Positive NewsGap DownEDAPEdap Tms3.0714 of 5 stars$1.50-1.0%$8.50+468.6%-70.1%$55.90M$69.18M-2.41230QTIQT ImagingN/A$1.98-4.8%N/A+194.2%$53.73M$4.00M0.00N/A Related Companies and Tools Related Companies SRTS Alternatives ZYXI Alternatives CTSO Alternatives RBOT Alternatives MDAI Alternatives SURG Alternatives ICCM Alternatives SPAI Alternatives EDAP Alternatives QTI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s #1 America First StockAmerica’s industrial comeback is underway — and it’s bigger than anyone expected. Over $5 trillion has alre...Weiss Ratings | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhat I told my neighbor to do with his moneyWhen a close friend inherited money, Joel Litman gave him the same investment advice he gives his own mom. ...Altimetry | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.